Like Duchenne muscular dystrophy, Becker muscular dystrophy typically affects only males (1 in 30,000) and causes heart problems. Disease severity varies. ... Muscle biopsy.

For Duchenne and Becker muscular dystrophies, muscle biopsy may show whether dystrophin, a muscle protein, is missing or abnormal, and DNA testing is used to analyze the condition of the related ...

Duchenne muscular dystrophy (DMD) is a rare neurological condition that causes severe muscle weakness and intellectual disability. DMD is an inherited (passed down) disorder. The condition is ...

WVE-N531 demonstrated statistically significant improvements in muscle biopsy measures and functional measures in patients with Duchenne muscular dystrophy (DMD) in the phase 2 FORWARD-53 trial ...

Lerario A et al. Quantitative Muscle Strength Assessment in Duchenne Muscular Dystrophy: Longitudinal Study and Correlation With Functional Measures. BMC Neurology . September 13, 2012.

DMD was first described by French neurologist Guillaume Benjamin Amand Duchenne in the 1860s. However, until the 1980s, little was known about the causes of any type of muscular dystrophy.

Unfortunately, the heart muscle doesn't appear to be more mildly affected than the hearts of Duchenne muscular dystrophy ...

Cite this: Association of Duchenne Muscular Dystrophy With Autism Spectrum Disorder - Medscape - Oct 01, 2005. Abstract and Introduction; ... Muscle Biopsy Dystrophin Deletion by PCR ...

Amid readouts from the Muscular Dystrophy Association’s annual meeting, the Clinical Trials Arena evaluates five DMD trials to keep an eye on in 2025.

Melanie Sanford fought to get her son Hudson a breakthrough gene therapy to stop the progression of the fatal disease Duchenne Muscular Dystrophy. She rushed to get him access just days before he ...

Shares of Sarepta Therapeutics have plunged again after the drugmaker reported a second death in connection with its gene therapy for muscular dystrophy.